Gert De Meerleer

3PUBLICATIONS
17CO-AUTHORS
Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Nov 07, 2024
The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial.

Kato Rans, Karolien Goffin, Steven Joniau

|Nov 10, 2022
Post-prostatectomy radiotherapy: does late toxicity lead the game?

Gert De Meerleer

|Dec 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial.

Cédric Draulans, Steven Joniau, Valérie Fonteyne

Pageof 1

Frequent Collaborators

1 joint publications

Cédric Draulans

1 joint publications

Steven Joniau

1 joint publications

Valérie Fonteyne

1 joint publications

Louke Delrue

1 joint publications

Karel Decaestecker

1 joint publications

Wouter Everaerts

1 joint publications

Piet Dirix

1 joint publications

Laura Van den Bergh

1 joint publications

Wouter Crijns

1 joint publications

Hans Vandendriessche

Frequent Collaborators

1 joint publications

Cédric Draulans

1 joint publications

Steven Joniau

1 joint publications

Valérie Fonteyne

1 joint publications

Louke Delrue

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.0K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

9.5K
See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.0K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

9.5K
See more related videos